Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does AMMONIUM GLYCYRRHIZATE Cause Hepatic function abnormal? 8 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Hepatic function abnormal have been filed in association with AMMONIUM GLYCYRRHIZATE. This represents 27.6% of all adverse event reports for AMMONIUM GLYCYRRHIZATE.

8
Reports of Hepatic function abnormal with AMMONIUM GLYCYRRHIZATE
27.6%
of all AMMONIUM GLYCYRRHIZATE reports
5
Deaths
7
Hospitalizations

How Dangerous Is Hepatic function abnormal From AMMONIUM GLYCYRRHIZATE?

Of the 8 reports, 5 (62.5%) resulted in death, 7 (87.5%) required hospitalization, and 4 (50.0%) were considered life-threatening.

Is Hepatic function abnormal Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for AMMONIUM GLYCYRRHIZATE. However, 8 reports have been filed with the FAERS database.

What Other Side Effects Does AMMONIUM GLYCYRRHIZATE Cause?

Blood urea increased (7) Weight increased (7) Blood alkaline phosphatase increased (6) Blood creatinine increased (6) Cardiac failure acute (6) Drug-induced liver injury (6) Drug ineffective (6) Gamma-glutamyltransferase increased (6) Thrombotic microangiopathy (6)

What Other Drugs Cause Hepatic function abnormal?

NIVOLUMAB (1,131) PEMBROLIZUMAB (1,079) METHOTREXATE (1,054) CABOZANTINIB S-MALATE (912) CYCLOPHOSPHAMIDE (824) BEVACIZUMAB (769) PACLITAXEL (603) LENVATINIB (528) ATORVASTATIN (520) CYCLOSPORINE (508)

Related Pages

AMMONIUM GLYCYRRHIZATE Full Profile All Hepatic function abnormal Reports All Drugs Causing Hepatic function abnormal AMMONIUM GLYCYRRHIZATE Demographics